Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected individuals. The underlying mechanism and source of this distinct immunologi...

Descrición completa

Detalles Bibliográficos

Principais autores:	Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra, Emily Long, Amruta Pise, Hallison Rodrigues, Eric Hall, Monica Herrera, Purvi Parikh, Jose Guevara-Coto, Timothy J. Triche, Paul Scott, Saboor Hekmati, Dennis Maglinte, Xaiolan Chang, Rodrigo A. Mora-Rodríguez, Javier Mora
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Immunology
Assuntos:	COVID-19 PASC SARS CoV-2 S1 protein non-classical monocytes CCR5 fractalkine
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.746021/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!